Climb Global Solutions, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Climb Global Solutions, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	418	449	181	209	252	283	304	352	466	653
Cost of revenue	391	422	155	179	219	237	250	288	375	547
Gross profit	27.3	27.1	26.9	30	33	45.7	54.1	64.2	91.1	105
Selling, general and administrative	18.7	19.3	20.3	20.9	23.9	32.1	34.1	44.3	56.5	67.6
General and administrative	9.14	9.43	9.69	9.26	9.71	12.8	14	16.6	19.2	20.5
Operating income	8.62	7.81	4.16	8.47	5.3	12.1	17.3	16.5	28	29.2
Pre-tax income	8.93	8.55	5.12	9.05	6.22	12.4	16.5	16.8	25	27.9
Income tax	3.03	3.49	1.58	2.26	1.75	3.17	4.04	4.46	6.41	6.59
Net income	5.9	5.06	3.54	6.79	4.47	9.2	12.5	12.3	18.6	21.3
EBITDA	8.91	8.29	4.64	8.95	6.02	13.6	19.4	19.3	32.3	36.9
EPS, basic	1.25	1.13	0.78	1.51	1.01	2.09	2.81	2.72	4.06	4.64
EPS, diluted	1.25	1.13	0.78	1.51	1.01	2.09	2.81	2.72	4.06	4.64
Shares, basic (weighted)	4.5	4.3	4.36	4.42	4.29	4.27	4.33	4.4	4.47	4.52
Shares, diluted (weighted)	4.5	4.3	4.36	4.42	4.29	4.27	4.33	4.4	4.47	4.52
Dividend per share	0.68	0.68	0.68	0.68	0.68	0.68	0.68	0.68	0.68	0.68

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	13.5	5.53	14.9	15	29.3	29.3	20.2	36.3	29.8	36.6
Receivables	83.8	78.2	81.4	101	93.8	123	155	222	342	324
Inventory	2.32	2.79	1.47	2.76	4.94	2.02	4.77	3.74	2.45	2.5
Other current assets	0.95	1.72	1.99	2.72	3.84	4.87	4.14	6.76	6.87	10.8
Total current assets	101	95.1	103	122	133	159	185	269	381	374
Property, plant and equipment	1.94	1.83	1.59	1.22	2.31	1.93	3.52	8.85	12.9	13.3
Lease right-of-use assets				1.79	1.93	1.63	1.24	0.88	1.97	1.72
Goodwill					16.8	17.2	19	27.2	34.9	36.8
Intangible assets				0	10.6	9.95	19.7	26.9	36.6	32.2
Other non-current assets	0.11	0.23	0.22	0.11	0.26	0.46	0.35	1.08	0.82	0.51
Total assets	116	105	108	126	166	191	232	335	469	460
Accounts payable	72.1	60.1	62.8	73.3	107	126	151	219	332	310
Accrued liabilities	3.99	5.12	3.9	5.05	9.65	8.36	8.46	22.9	17.2	26.8
Short-term debt								0.54	0.56	0.19
Total current liabilities	76.1	65.2	66.7	78.7	117	135	162	251	372	337
Long-term debt								0.75	0.19	0
Lease liabilities				2.19	2.17	1.81	1.3	0.88	1.69	1.22
Other non-current liabilities			0.75	0.09			2.87	2.51	0.38	0.03
Total liabilities	76.1	66	67.4	81	121	138	171	260	379	344
Total debt						0	1.8	1.3	0.19	0
Paid-in capital	30.7	31.3	32.4	32.9	32	32.1	32.7	34.6	38	42.3
Retained earnings	20.5	22.5	23	26.7	28.2	34.4	43.9	53.2	68.8	87
Treasury stock	-12	-14.2	-13.4	-13.3	-14.7	-13.9	-13.2	-12.6	-13.3	-14.9
Other comprehensive income	-1.61	-0.91	-1.42	-1.13	-0.74	-0.25	-2.87	-0.52	-2.89	2.06
Shareholders' equity	37.6	38.7	40.6	45.3	44.7	52.4	60.6	74.8	90.6	117
Total equity	37.6	38.7	40.6	45.3	44.7	52.4	60.6	74.8	90.6	117
Total liabilities and equity	114	105	108	126	166	191	232	335	469	460
Shares outstanding	4.56	4.45	4.5	4.51	4.36	4.42	4.48	4.57	4.6	18.4

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	5.9	5.06	3.54	6.79	4.47	9.2	12.5	12.3	18.6	21.3
Depreciation and amortization	0.3	0.48	0.48	0.49	0.71	1.53	2.07	2.8	4.27	7.73
Stock-based compensation	1.67	1.51	2.77	0.76	1.28	1.55	1.9	4.15	4.07	4.78
Deferred income tax	0.11	0.28	-0.01	-0.11	-0.17	0.23	-0.54	-0.38	-0.51	-0.11
Change in receivables	-28.3	11.5	1.54	-17.1	26.7	-28.6	-35.8	-29.6	-124	25.6
Change in inventory	-0.36	-0.46	1.31	-1.28	-2	2.91	-2.75	3.6	1.2	0.11
Change in payables	21.2	-12.7	1.84	11.6	8.68	18.6	25.4	49.7	127	-40.2
Cash from operations	-0.52	-2.02	13.9	3.25	38	4.71	4.56	42.1	33.7	16.6
Capital expenditures	-1.04	-0.36	-0.27	-0.11
Acquisitions					-16.8			-12.7	-21	0
Cash from investing	-1.04	-0.36	-0.27	-0.11	-16.8	-0.26	-11	-17.7	-26.4	-2
Share buybacks	-5.4	-2.95	-1.04	-0.09	-3.68	-0.54	-0.66	-1.71	-1.59	-2.05
Dividends paid	-3.2	-3.06	-3.07	-3.07	-3	-2.99	-2.99	-3.01	-3.04	-3.08
Cash from financing	-8.46	-6.01	-4.11	-3.15	-6.74	-4.4	-1.83	-8.95	-13	-9.06
Exchange rate effect	-0.28	0.4	-0.18	0.11	-0.06	-0.13	-0.74	0.54
Net change in cash	-10.3	-7.99	9.35	0.1	14.4	-0.08	-9.03	16.1
Free cash flow	-1.56	-2.38	13.6	3.14
Interest paid				0.05	0.05	0.04	0.05	0.18	0.21	0.14
Income taxes paid	2.56	2.44	2.34	2.39	2.43	2.7	4.28	5.43	4.07	9.94

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $31.65 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	15.8%	Gross profit / revenue.
Operating margin	3.9%	Operating income / revenue.
EBITDA margin	5.0%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	3.9%	Pre-tax income / revenue.
Net margin	2.9%	Net income / revenue.
Operating cash flow margin	6.0%	Cash from operations / revenue.
Effective tax rate	25.7%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	16.4%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	4.4%	Net income / average total assets.
Return on invested capital (ROIC)	30.1%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	10.6%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.7%	Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue	1.1%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	40.1%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	28.9%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	21.0%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	15.6%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	24.8%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	26.1%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	4.3%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	19.0%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	40.6%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	14.4%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	24.0%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	43.7%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	14.6%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	19.5%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	36.7%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	14.3%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	18.2%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	35.7%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-50.8%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	53.8%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-15.2%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	0.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	0.0%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	0.0%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	28.7%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	24.4%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	21.1%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-1.9%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	25.7%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	22.7%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	1.3%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	1.5%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	1.1%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.13x	Current assets / current liabilities.
Quick ratio	1.07x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.17x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	73.0%	Total liabilities / total assets.
Working capital	$41.1M	Current assets - current liabilities.
Goodwill and intangibles / assets	16.5%	(Goodwill + intangible assets) / total assets.
Tangible book value	$48.5M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.54x	Revenue / average total assets.
Fixed asset turnover	52.2x	Revenue / average property, plant and equipment.
Inventory turnover	131x	Cost of revenue / average inventory.
Days inventory	3 days	365 x average inventory / cost of revenue.
Receivables turnover	2.41x	Revenue / average receivables.
Days sales outstanding	151 days	365 x average receivables / revenue.
Days payables	178 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	-24 days	Days inventory + days sales outstanding - days payables.

Per share

Metric	Value	How it is calculated
EPS, diluted	$1.12	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$38.90	Revenue / diluted weighted shares.
Operating cash flow per share	$2.32	Cash from operations / diluted weighted shares.
Book value per share	$6.70	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$2.60	Tangible book value / shares outstanding.
Cash per share	$3.03	(Cash + short-term investments) / shares outstanding.
Payout ratio	7.5%	Dividends paid / net income, when net income is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$590.6M	Share price x shares outstanding.
Enterprise value	$534.0M	Market cap + total debt - cash - short-term investments.
P/E	28.8x	Market cap / net income. Only when net income is positive.
P/S	0.83x	Market cap / revenue.
P/B	4.73x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	12.2x	Market cap / tangible book value, when positive.
P/OCF	13.9x	Market cap / cash from operations, when positive.
EV/Sales	0.75x	Enterprise value / revenue.
EV/EBIT	19.3x	Enterprise value / operating income, when both are positive.
EV/EBITDA	14.9x	Enterprise value / EBITDA, when both are positive.
Earnings yield	3.5%	Net income / market cap (the inverse of P/E).
Dividend yield	0.3%	Dividends paid over the period / market cap.
Shareholder yield	0.6%	(Dividends paid + share buybacks) / market cap.
PEG	1.58x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was Climb Global Solutions, Inc.'s revenue in fiscal 2025?

Climb Global Solutions, Inc. reported revenue of $652.5M for fiscal 2025, 40.1% higher than the year before.

Was Climb Global Solutions, Inc. profitable in fiscal 2025?

Yes. Net income was $21.3M, a net margin of 3.3%.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Climb Global Solutions, Inc.